| NAME |
DARBEPOETIN ALFA,RECOMBINANT 300MCG/ML INJ W/ALBUMIN FREE |
| VA GENERIC NAME |
DARBEPOETIN ALFA,RECOMBINANT |
| DOSAGE FORM |
INJ,SOLN |
| FDA MED GUIDE |
Darbepoetin_(Aranesp)_(2018).pdf |
| ACTIVE INGREDIENTS |
|
| CS FEDERAL SCHEDULE |
Unscheduled |
| STRENGTH |
300 |
| SINGLE/MULTI SOURCE PRODUCT |
Single source |
| INACTIVATION DATE |
2022-01-15 00:00:00 |
| UNITS |
MCG/ML |
| NATIONAL FORMULARY NAME |
DARBEPOETIN ALFA,RECOMBINANT INJ,SOLN |
| CREATE DEFAULT POSSIBLE DOSAGE |
YES |
| CODING SYSTEM |
|
| COPAY TIER |
-
- COPAY TIER LEVEL: 3
- COPAY EFFECTIVE DATE: 2017-02-27 00:00:00
- COPAY END DATE: 2021-09-22 00:00:00
-
- COPAY TIER LEVEL: 2
- COPAY EFFECTIVE DATE: 2021-09-23 00:00:00
|
| PGX ELIGIBLE |
NO |
| PGX SUPPRESSED |
NO |
| VA PRINT NAME |
DARBEPOETIN ALFA 300MCG/ML ALBUMIN FREE |
| VA PRODUCT IDENTIFIER |
D0808 |
| TRANSMIT TO CMOP |
YES |
| VA DISPENSE UNIT |
ML |
| MASTER ENTRY FOR VUID |
YES |
| VUID |
4028611 |
| EFFECTIVE DATE/TIME |
-
- 2009-05-11 00:00:00
- STATUS: ACTIVE
-
- 2022-01-15 00:00:00
- STATUS: INACTIVE
|
